NZ GP Practice Review Issue 13

In this issue:
– A progressive approach to managing atrial fibrillation
– Combination treatment with GLP-1 receptor agonists and SGLT-2 inhibitors reduces CV events
– Interacting safely with low-dose methotrexate
– Effectiveness of continuous glucose monitoring on glycaemic control in T2D
– Assessing, communicating and managing cardiovascular disease risk
– PDE-5 inhibitors and cardiac health guidelines
– Physician associates in New Zealand primary health care
– Seasonal influenza vaccinations
– Restrictions on funded GLP-1 receptor agonists
– COPD single inhaler triple therapy to be funded
– Shingles vaccine funded for select immunocompromised people
– HIV combination treatment funded
– Niraparib funded for ovarian cancer
– Funding proposal for T1D
– Monitoring communication: Calcium channel blockers and new-onset eczema
– ACC rongoā Māori YouTube channel
– Your Work Counts diary study
– Should primary care proactively take up AI?
– ADHD treatment in Aotearoa